The use of prophylactic vancomycin to prevent MRSA colonization: does this double-edged sword promote future vancomycin resistance or is it a safe preventative strategy that should be used in all patients in the context of MRSA endemicity?

Minerva Anestesiol. 2010 Mar;76(3):175-7.
No abstract available

Publication types

  • Comment
  • Editorial

MeSH terms

  • Anti-Bacterial Agents / therapeutic use*
  • Antibiotic Prophylaxis / methods*
  • Cross Infection / prevention & control
  • Humans
  • Methicillin-Resistant Staphylococcus aureus*
  • Staphylococcal Infections / epidemiology
  • Staphylococcal Infections / prevention & control*
  • Vancomycin / therapeutic use*

Substances

  • Anti-Bacterial Agents
  • Vancomycin